Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Scott W. Andersen, MS
JCP
Original Research
Long-Term Weight Gain in Patients Treated With Open-Label Olanzapine in Combination With Fluoxetine for Major Depressive Disorder
November 15, 2005
Scott W. Andersen
,
David B. Clemow
,
Sara A. Corya
JCP
Original Research
Long-Term Antidepressant Efficacy and Safety of Olanzapine/Fluoxetine Combination: A 76-Week Open-Label Study
November 15, 2003
Sara A. Corya
,
Scott W. Andersen
,
Holland C. Detke
, et al
JCP
Article
Should We Consider Mood Disturbance in Schizophrenia as an Important Determinant of Quality of Life?
May 1, 1999
Gary D. Tollefson
,
Scott W. Andersen